Wissenschaftliche Veröffentlichungen

Wüster C, Bucher M, Manegold C, Schmidt J, Ziegler R, Drings P (1991)

Methylpentylaminoprolidene Bisphosphonate (BM 210955) in The Treatment of Hypercalcemia of Malignancy
Onkologie 14, Suppl. 3: 20

Badea R, Badea Gh, Galtar N, Craciun C, Marin M, Bucher M (1991)
Die Bedeutung der aspirativen Feinnadelbiopsie in der Präzisierung ultraschalldiagnostizierter Lebertumoren Untersuchungen an 165 Patienten
Z Klin Med 46: 1489-1493

Wüster C, Bucher M, Manegold C, Schmid J (1992)
Methylpenthylaminopropyliden (BM 210955) bei der Behandlung der Tumorhyperkalzämie
J Can Res and Clin Oncol 118, Suppl.: 149

Bischoff HG, Layer G, Manegold C, Bucher M, Knopp P, Drings P (1992)

Improvement in the Staging of Small Cell Lung Cancer (SCLC) by MRI of Bone Marrow

The European Respiratory Journal 5, Suppl. 15 : 439

Bucher M, Manegold C, Krempien B, Fischer JR, Drings P (1992)

Human Epithelial Antigen (HEA) 125-Positive Cells in the Bone Marrow of Small Cell Lung Cancer (SCLC)

Bucher M, Manegold C, Sterz R, Drings P (1992)

Effectiveness of the new Bisphosphonate BM 21.0955 in

Hypercalcemia of Malignancy in Patients with Lung Cancer

Xlth ICCRH Conference, Satellite Workshop Sienna 1992

Bucher M, Manegold C, Krempien B, Fischer JR, Drings P (1992)

Human Epithelial Antigen (HEA) 125-Postive Cells in the Bone Marrow of Small Cell Lung Cancer (SCLC)

The European Respiratory Journal 5, Suppl. 15 : 382

Annals of Hematology 65, Suppl.: 42 Manegold C, Bucher M, Hug G, Drings P (1993)

Phase-II-Study of Oral Ifosfamide (01)/ Mesna (M) in Small Cell Lung Cancer (SCLC)

Bucher M, Manegold C, Sterz R, Drings P (1993)

Effectiveness of the new Bisphosphonate BM 21.0955 in Hypercalcemia of Malignancy in Patients with Lung Cancer

Int. Symposium Supportive Care in Cancer, St. Gallen 1993

Blind E, Kaue F, Meinel T, Bucher M, Manegold C, Ebert W, Vogt-Moykopf I, Ziegler R (1993)

Levels of paratyroid hormone-related protein in Hypercalcemia of malignancy: comparasion of midregional radioimmunassay and two-site immunoradiometric assay

Clin Investig 71: 31-36

Bischoff HG, Knopp MV, Bucher M, Manegold C, van Kaick G, Drings P (1993)

Clinical application of FDG-PET imaging in management of malignant pleural mesothelioma

The European Respiratory Journal 6, Suppl. 17: 140

ASCO Annual Meeting 1993

Bucher M, Manegold C, Krempien B, Drings P (1994)

The role of immunocytological staining on bone marrow aspirates for staging small cell lung cancer (SCLC)

Cancer Research and Clinical Oncology, Vol 120, Suppl: R

Hagemeyer 0, Bucher M, Schrenk B, Bülzebruck H, Drings P, Schulz V (1994)

Correlation between both time of initial diagnosis and survival in lung cancer and profession

Cancer Rearch and Clinical Oncology, Vol 120, Suppl: R 25

Bucher M, Manegold C, Krempien B, Drings P (1994)

The role of immunocytological staining on bone marrow aspirates for staging small cell lung cancer (SCLC)

Cancer Research and Clinical Oncology, Vol 120, Suppl: R

Hagemeyer 0, Bucher M, Schrenk B, Bülzebruck H, Drings P, Schulz V (1994)

Correlation between both time of initial diagnosis and survival in lung cancer and profession

Cancer Rearch and Clinical Oncology, Vol 120, Suppl: R 25

Bucher M., Meinel Th., Manegold C., Drings P., Raue F., Herrmann Z (1994)

The new bisphosphonate BM 21.0955 in the treatment of hypercalcemia of malignancy in mallignant mesothelioma

Supp. Care in Cancer New Orleans 1994

Manegold C., Bucher M., Krempien B., Bülzebruck H., Drings P. (1994)

Immunocytological evidence of tumor cells (lETC) spread to bone marrow and its relationship to prognosis in small cell lung cancer cancer (SCLC)

7 th World Conference on Lung Cancer Juni 1994

Bischoff H.G., Bucher M., Knopp M.V., Krempien B., Manegold C. (1994)

Bone marrow MRI and immunocytological staining with HEA- 125 – new tools in staging small cell lung cancer 

Onkologie, Band 17, Suppl. 2: 10

Bucher M., Manegold C., Krempien B., Drings P (1994)

Immunocytological staining with HEA-125 on bone marrow aspirates for staging small cell lung cancer

The European Respiratory Journal 7, Suppl. 18: 305

Bucher M., Manegold C., Krempien B., Drings P. (1994)

Immunocytological staining with HEA-125 on bone marrow aspirates for staging small cell lung cancer (SCLC)

Annals of Oncology 5, Suppl. 8: 163

Kröger H., Klüppelberg F., Manke H.G., Bucher M., Kayser K., Möller P., Manegold C.

Primär pulmonale Lymphome- Beobachtung anhand von 7 Fallbeschreibungen

Bucher M., Hagemeyer 0., Bülzebruck H., Drings P., Baur X. (1994)

Besteht ein Zusammnenhang zwischen der beruflichen Tätigkeit und dem Erkrankungsalter sowie der Überlebenszeit beim Bronchialkarzinom 

Atemwegs-und Lungenkrankheiten, Heft 11:

Bischoff H.G., Bucher M., Knopp M.V., Krempien B., Manegold C. (1994)

The role of bone marrow MRI and immunocytological staining with HEA-125 in the staging of SCLC

Annals of Oncology 5, Suppl. 8: 163

Bucher M., Hagemeyer 0., Bülzebruck H., Drings P., Baur X. (1994)

Besteht ein Zusammnenhang zwischen der beruflichen Tätigkeit und dem Erkrankungsalter sowie der Überlebenszeit beim Bronchialkarzinom 

Atemwegs-und Lungenkrankheiten, Heft 11:

Bischoff H.G., Bucher M., Knopp M.V., Krempien B., Manegold C. (1994)

The role of bone marrow MRI and immunocytological staining with HEA-125 in the staging of SCLC

Annals of Oncology 5, Suppl. 8: 163